Neochem Bio Solutions Ltd. IPO: Complete Review & Analysis

Neochem Bio Solutions IPO| Neochem Bio IPO GMP| Neochem Bio Solutions Ltd IPO date| SME IPO review 2025| Neochem Bio price band

Neochem Bio Solutions Ltd. is set to hit the primary market with its SME IPO opening on December 2, 2025. As a specialty performance chemical manufacturer with over four decades of legacy (including its predecessors), the company is garnering attention for its diverse product portfolio.

Here is a detailed breakdown of the issue, financial health, and investment potential.

1. IPO Details at a Glance

Parameter	Details
IPO Open Date	December 2, 2025
IPO Close Date	December 4, 2025
Listing Date (Tentative)	December 9, 2025
Face Value	₹10 per share
Price Band	₹93 to ₹98 per share
Lot Size	1,200 Shares
Total Issue Size	Approx ₹44.97 Cr
Listing Exchange	NSE SME
Retail Investment (Min)	₹1,17,600 (at lower band) – ₹1,17,600

2. Business Model

Neochem Bio Solutions operates in the Specialty Performance Chemicals sector. They manufacture over 350 customized formulations spread across four key segments:

1. Polymers
2. Surfactants
3. Silicones
4. Esters & Bio-based Solutions

Key Industries Served:

• Textile & Garment Washing
• Home & Personal Care (HPC)
• Water Treatment
• Paints & Coatings
• Construction

3. Financial Performance (Restated)

The company has shown robust growth leading up to the IPO.

• Revenue Growth: Revenue jumped significantly from ₹62.01 Cr in FY24 to ₹86.15 Cr in FY25.
• Profitability: Profit After Tax (PAT) saw a massive surge, rising to ₹7.75 Cr in FY25 from just ₹1.80 Cr in FY24.
• Margins: The company boasts strong return ratios with an ROE of 48.82% and ROCE of 41.67% (as of FY25 data).
• Debt: The Debt-to-Equity ratio stands at 1.80, which is on the higher side and is a key metric for investors to watch.

4. Objectives of the Issue

The funds raised from the IPO will be utilized for:

• Working Capital: Funding long-term working capital requirements (₹23.90 Cr).
• Debt Reduction: Repayment or prepayment of outstanding borrowings (₹10.00 Cr).
• General Corporate Purposes: To support business growth and operations.

5. Neochem Bio IPO GMP (Grey Market Premium)

(Note: GMP is volatile and changes daily.)

As of late November 2025, the Grey Market Premium (GMP) is currently flat or reporting no major movement (₹0).

• Expected Listing Price: ₹98 (at cap price)
• Listing Gain: ~0% (Based on current GMP)

Investors should monitor GMP closely as the issue opening date approaches, as SME IPOs often see sudden shifts in sentiment.

6. Review: Should You Apply?

Strengths:

• Diversified Portfolio: Not reliant on a single industry; serves textiles, construction, and personal care.
• High Growth: The jump in PAT in FY25 is impressive.
• Valuation: The P/E ratio appears competitive compared to peers like Rossari Biotech.

Risks:

• Debt Levels: A debt-to-equity ratio of 1.80 is high, though IPO proceeds will help reduce this.
• SME Liquidity: Like all SME IPOs, liquidity can be lower than mainboard IPOs, and lot sizes are larger.

Conclusion:

Neochem Bio Solutions presents a high-growth opportunity in the chemical sector. However, the high debt and flat GMP suggest a cautious approach. It may be suitable for high-risk investors looking for long-term value rather than immediate listing pops, unless GMP improves before the issue opens.

• 45 Weeks. 45 Lessons. From Basics to Advanced – Master Stock Market Investing in Less than 1 Year.
• Lesson 1: What is a Stock Market? Beginner’s Guide to Understanding Shares & Trading
• Lesson 2: How Does the Stock Market Work? The Secret Engine of the Stock Market – Explained Simply

Neochem Bio Solutions IPO| Neochem Bio IPO GMP| Neochem Bio Solutions Ltd IPO date| SME IPO review 2025| Neochem Bio price band

---

Subscription:

Date	Anchor	QIB	NII	BNII(>10l)	SNII(<10L)	Retail	Total

---

How to Check IPO Allotment Status:

---

---

📌 Stock Market Disclaimer

• Disclaimer: This post is for informational and educational purposes only and does not constitute financial advice or a recommendation to buy/sell any stock or share. Investing in the stock market involves risk. Past performance is not indicative of future results. Always conduct your own research or consult a licensed financial advisor before making investment decisions.
• The information provided on this platform is for educational and informational purposes only. It should not be considered as investment advice, stock recommendations, or financial guidance.
• ⚠️ Stock Market Investments
• Investing in equities, derivatives, mutual funds, and other financial instruments involves market risks, volatility, and the possibility of capital loss.
• Past performance of stocks or indices is not indicative of future returns.
• Always conduct your own research or consult a SEBI-registered financial advisor before making investment decisions.
• ⚠️ IPO (Initial Public Offerings)
• IPO details, issue size, subscription data, and allotment status shared here are based on publicly available information from company filings, stock exchanges, and merchant bankers.
• Investing in IPOs carries risks including listing volatility, business uncertainties, and sector performance dependency.
• Neither acceptance of applications nor allotment guarantees profits. Investors should evaluate their risk appetite before subscribing.
• ⚠️ GMP (Grey Market Premium)
• Grey Market Premium (GMP) is an unofficial and unregulated indicator of expected IPO listing price.
• GMP data is collected from market observers and informal trading circles; it does not have any legal or SEBI recognition.
• GMP values are highly speculative and may differ significantly from actual listing prices. Investors should not rely solely on GMP while taking investment decisions.
• ✅ General Advisory
• We do not provide any buy/sell/hold recommendations.
• Readers and investors are solely responsible for their investment actions and decisions.
• This platform, its authors, and affiliates are not liable for any direct or indirect financial loss arising from the use of this information.
• 🔒 Always invest responsibly and diversify your portfolio.

Open Demat Account

by Mirae Asset (m,Stock)